MaveriX Oncology Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $6.5M
Latest Deal Amount
  • Investors
  • 2

MaveriX Oncology General Information

Description

Developer of novel immunotherapies designed to bridge the therapeutic gap in cancer treatment The company's immunotherapies leverages unexploited insights into cancer and immune cell metabolism within the tumor microenvironment which are common to all cancers, enabling medical practitioners to selectively deliver the tumor cell killing benefits of chemotherapy while generating a strong immune response to attack a wide range of cancers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 435 Middlefield Road
  • Palo Alto, CA 94301
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MaveriX Oncology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 14-Oct-2019 $6.5M 00.00 0000 Completed Clinical Trials - Phase 1
1. Angel (individual) 02-Jun-2016 000000 Completed Startup
To view MaveriX Oncology’s complete valuation and funding history, request access »

MaveriX Oncology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view MaveriX Oncology’s complete cap table history, request access »

MaveriX Oncology Executive Team (3)

Name Title Board Seat Contact Info
Steven Everett Ph.D Co-Founder, President, Chief Executive Officer, Chief Scientific Officer & Board Member
Chris Bowers Chief Operating Officer
You’re viewing 2 of 3 executive team members. Get the full list »

MaveriX Oncology Board Members (4)

Name Representing Role Since
Kim Nearing MaveriX Oncology Board Member 000 0000
Norbert Prenzel MaveriX Oncology Board Member 000 0000
Riccardo Panicucci Ph.D MaveriX Oncology Board Member 000 0000
Steven Everett Ph.D MaveriX Oncology Co-Founder, President, Chief Executive Officer, Chief Scientific Officer & Board Member 000 0000
To view MaveriX Oncology’s complete board members history, request access »

MaveriX Oncology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MaveriX Oncology Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
PPF Group PE/Buyout Minority 000 0000 000000 0
SOTIO PE-Backed Company Minority 000 0000 000000 0
To view MaveriX Oncology’s complete investors history, request access »